Journal of Medicinal Chemistry
Page 22 of 23
(10) Maly, D. J.; Choong, I. C.; Ellman, J. A., Combinatorial target-
colitis with a tryptase inhibitor (APC 2059): an open-label pilot
guided ligand assembly: Identification of potent subtype-selective
c-src inhibitors. Proc. Natl. Acad. Sci. USA 2000, 97, 2419-2424.
(11) Suzuki, T.; Ota, Y.; Kasuya, Y.; Mutsuga, M.; Kawamura, Y.;
Tsumoto, H.; Nakagawa, H.; Finn, M. G.; Miyata, N., An unexpected
example of protein-templated click chemistry. Angew. Chem. Int.
Ed. 2010, 49, 6817-6820.
(12) Lewis, W. G.; Green, L. G.; Grynszpan, F.; Radic, Z.; Carlier, P.
R.; Taylor, P.; Finn, M. G.; Sharpless, K. B., Click chemistry in situ:
acetylcholinesterase as a reaction vessel for the selective assembly
of a femtomolar inhibitor from an array of building blocks. Angew.
Chem. Int. Ed. 2002, 41, 1053-1057.
study. Aliment. Pharmacol. Ther. 2002, 16, 407-413.
(29) Caughey, G. H., Mast cell proteases as pharmacological
targets. Eur. J. Pharmacol. 2016, 778, 44-55.
1
2
3
4
5
6
7
8
(30) Reber, L. L.; Frossard, N., Targeting mast cells in
inflammatory diseases. Pharmacol. Ther. 2014, 142, 416-435.
(31) Demetriades, M.; Leung, I. K. H.; Chowdhury, R.; Chan, M. C.;
McDonough, M. A.; Yeoh, K. K.; Tian, Y.-M.; Claridge, T. D. W.;
Ratcliffe, P. J.; Woon, E. C. Y.; Schofield, C. J., Dynamic combinatorial
chemistry employing boronic acids/boronate esters leads to
potent oxygenase inhibitors. Angew. Chem. Int. Ed. 2012, 51, 6672-
6675.
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
(13) Mammen, M.; Choi, S.-K.; Whitesides, G. M., Polyvalent
interactions in biological systems: implications for design and use
of multivalent ligands and inhibitors. Angew. Chem. Int. Ed. 1998,
37, 2754-2794.
(14) Braisted, A. C.; Oslob, J. D.; Delano, W. L.; Hyde, J.; McDowell,
R. S.; Waal, N.; Yu, C.; Arkin, M. R.; Raimundo, B. C., Discovery of a
potent small molecule IL-2 inhibitor through fragment assembly. J.
Am. Chem. Soc. 2003, 125, 3714-3715.
(15) Erlanson, D. A.; McDowell, R. S.; O'Brien, T., Fragment-based
drug discovery. J. Med. Chem. 2004, 47, 3463-3482.
(16) Hajduk, P. J.; Greer, J., A decade of fragment-based drug
design: strategic advances and lessons learned. Nat. Rev. Drug
Discov. 2007, 6, 211-219.
(17) Rees, D. C.; Congreve, M.; Murray, C. W.; Carr, R., Fragment-
based lead discovery. Nat. Rev. Drug Discov. 2004, 3, 660-672.
(18) Rideout, D., Self-assembling cytotoxins. Science 1986, 233,
561-563.
(19) Pereira, P. J. B.; Bergner, A.; Macedo-Ribeiro, S.; Huber, R.;
Matschiner, G.; Fritz, H.; Sommerhoff, C. P.; Bode, W., Human β-
tryptase is a ring-like tetramer with active sites facing a central
pore. Nature 1998, 392, 306-311.
(20) Schaschke, N.; Matschiner, G.; Zettl, F.; Marquardt, U.;
Bergner, A.; Bode, W.; Sommerhoff, C. P.; Moroder, L., Bivalent
inhibition of human β-tryptase. Chem. Biol. 2001, 8, 313-327.
(21) Maun, H. R.; Liu, P. S.; Franke, Y.; Eigenbrot, C.; Forrest, W.
F.; Schwartz, L. B.; Lazarus, R. A., Dual functionality of beta-tryptase
protomers as both proteases and cofactors in the active tetramer.
J. Biol. Chem. 2018, 293, 9614–9628.
(22) Bachelet, I.; Munitz, A.; Levi-Schaffer, F., Tryptase as an
inflammatory marker in allergic disease and asthma. Expert Rev.
Clin. Immuno. 2005, 1, 63-73.
(23) Trivedi, N. N.; Caughey, G. H., Mast cell peptidases:
chameleons of innate immunity and host defense. Am. J. Respir. Cell.
Mol. Biol. 2010, 42, 257-267.
(24) Liang, G.; Aldous, S.; Merriman, G.; Levell, J.; Pribish, J.;
Cairns, J.; Chen, X.; Maignan, S.; Mathieu, M.; Tsay, J.; Sides, K.;
Rebello, S.; Whitely, B.; Morize, I.; Pauls, H. W., Structure-based
library design and the discovery of a potent and selective mast cell
beta-tryptase inhibitor as an oral therapeutic agent. Bioorg. Med.
Chem. Lett. 2012, 22, 1049-1054.
(25) Schaschke, N.; Dominik, A.; Matschiner, G.; Sommerhoff, C.
P., Bivalent inhibition of beta-tryptase: distance scan of
neighboring subunits by dibasic inhibitors. Bioorg. Med. Chem. Lett.
2002, 12, 985-988.
(26) Burgess, L. E.; Newhouse, B. J.; Ibrahim, P.; Rizzi, J.; Kashem,
M. A.; Hartman, A.; Brandhuber, B. J.; Wright, C. D.; Thomson, D. S.;
Vigers, G. P. A.; Koch, K., Potent selective nonpeptidic inhibitors of
human lung tryptase. Proc. Natl. Acad. Sci. USA 1999, 96, 8348-
8383.
(27) Oh, S.-W.; Pae, C. I.; Lee, D.-K.; Jones, F.; Chiang, G. K. S.; Kim,
H.-O.; Moon, S.-H.; Cao, B.; Ogbu, C.; Jeong, K.-W.; Kozu, G.;
Nakanishi, H.; Kahn, M.; Chi, E. Y.; Henderson, W. R., Tryptase
inhibition blocks airway inflammation in a mouse asthma model. J.
Immunol. 2002, 168, 1992-2000.
(28) Tremaine, W. J.; Brzezinski, A.; Katz, J. A.; Wolf, D. C.;
Fleming, T. J.; Mordenti, J.; Strenkoski-Nix, L. C.; Kurth, M. C.; Group,
A. U. C. S., Treatment of mildly to moderately active ulcerative
(32) Shin, S. B. Y.; Almeida, R. D.; Gerona-Navarro, G.; Bracken,
C.; Jaffrey, S. R., Assembling ligands in situ using bioorthogonal
boronate ester synthesis. Chem. Biol. 2010, 17, 1171-1176.
(33) Costanzo, M. J.; Yabut, S. C.; Zhang, H. C.; White, K. B.; de
Garavilla, L.; Wang, Y.; Minor, L. K.; Tounge, B. A.; Barnakov, A. N.;
Lewandowski, F.; Milligan, C.; Spurlino, J. C.; Abraham, W. M.;
Boswell-Smith, V.; Page, C. P.; Maryanoff, B. E., Potent, nonpeptide
inhibitors of human mast cell tryptase. Synthesis and biological
evaluation of novel spirocyclic piperidine amide derivatives.
Bioorg. Med. Chem. Lett. 2008, 18, 2114-2121.
(34) Levell, J.; Astles, P.; Eastwood, P.; Cairns, J.; Houille, O.;
Aldous, S.; Merriman, G.; Whiteley, B.; Pribish, J.; Czekaj, M.; Liang,
G.; Maignan, S.; Guilloteau, J. P.; Dupuy, A.; Davidson, J.; Harrison, T.;
Morley, A.; Watson, S.; Fenton, G.; McCarthy, C.; Romano, J.;
Mathew, R.; Engers, D.; Gardyan, M.; Sides, K.; Kwong, J.; Tsay, J.;
Rebello, S.; Shen, L.; Wang, J.; Luo, Y.; Giardino, O.; Lim, H. K.; Smith,
K.;
Pauls,
H.,
Structure
based
design
novel,
of
4-(3-
potent,
aminomethylphenyl)piperidinyl-1-amides:
selective, and orally bioavailable inhibitors of beta II tryptase.
Bioorg. Med. Chem. 2005, 13, 2859-2872.
(35) Fang, G.; Wang, H.; Bian, Z.; Sun, J.; Liu, A.; Fang, H.; Liu, B.;
Yao, Q.; Wu, Z., Recent development of boronic acid-based
fluorescent sensors. RSC Advances 2018, 8, 29400-29427.
(36) Liang, G.; Choi-Sledeski, Y. M.; Poli, G. B.; Chen, X.; Minnich,
A.; Wang, Q.; Tsay, J.; Sides, K.; Vaz, R. J., Structure-based design,
synthesis, and profiling of a β-tryptase inhibitor with a spiro-
piperidineamide scaffold, benzylamine P1 group, and a substituted
indole P4 group. MedChemComm 2011, 2, 794-799.
(37) Costanzo, M. J.; Yabut, S. C.; Zhang, H.-C.; White, K. B.; Wang,
Y.; Minor, L. K.; Tounge, B. A.; Barnakov, A. N.; Lewandowski, F.;
Milligan, C.; Spurlino, J. C.; Maryanoff, B. E., Potent, nonpeptide
inhibitors of human mast cell tryptase. 2. Investigation of the
carboxamide portion of spirocyclic piperidine amides. Lett. Drug.
Des. Discov. 2008, 5, 116-121.
(38) Liang, G.; Choi-Sledeski, Y. M.; Shum, P.; Chen, X.; Poli, G. B.;
Kumar, V.; Minnich, A.; Wang, Q.; Tsay, J.; Sides, K.; Kang, J.; Zhang,
Y., A β-tryptase inhibitor with a tropanylamide scaffold to improve
in vitro stability and to lower hERG channel binding affinity.
Bioorg. Med. Chem. Lett. 2012, 22, 1606-1610.
(39). Liang, G.; Choi-Sledeski, Y. M.; Chen, X.; Gong, Y.;
MacMillan, E. W.; Tsay, J.; Sides, K.; Cairns, J.; Kulitzscher, B.; Aldous,
D. J.; Morize, I.; Pauls, H. W., Dimerization of beta-tryptase
inhibitors, does it work for both basic and neutral P1 groups?
Bioorg. Med. Chem. Lett. 2012, 22, 3370-3376.
(40) Trivedi, N. N.; Tong, Q.; Raman, K.; Bhagwandin, V. J.;
Caughey, G. H., Mast cell alpha and beta tryptases changed rapidly
during primate speciation and evolved from gamma-like
transmembrane peptidases in ancestral vertebrates. J. Immunol.
2007, 179, 6072-6079.
(41) Selwood, T.; Elrod, K. C.; Schechter, N. M., Potent bivalent
inhibition of human tryptase-beta by a synthetic inhibitor. Biol.
Chem. 2003, 384, 1605-1611.
(42) Sylvin, H.; Dahlback, M.; Van Der Ploeg, I.; Alving, K., The
tryptase inhibitor APC-366 reduces the acute airway response to
allergen in pigs sensitized to Ascaris suum. Clin. Exp. Allergy 2002,
32, 967-971.
ACS Paragon Plus Environment